AI is touching every aspect of alternative assets, but there are risks ahead, with overhype and regulatory uncertainty ...
De novo cholesterol biosynthesis is a key metabolic vulnerability in rhabdomyosarcoma. Its inhibition halts cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback